Mechanisms coupling the mTOR pathway to chronic obstructive pulmonary disease (COPD) pathogenesis
- 5 January 2025
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 82, 55-69
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
- Council of Scientific and Industrial Research, India
This publication has 107 references indexed in Scilit:
- The role of gut-lung axis in COPD: Pathogenesis, immune response, and prospective treatmentHeliyon, 2024
- Cigarette smoke triggers inflammation mediated by autophagy in BEAS-2B cellsEcotoxicology and Environmental Safety, 2019
- Pathogenic Role of mTORC1 and mTORC2 in Pulmonary HypertensionJACC: Basic To Translational Science, 2018
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Inflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2016
- The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsBBA Clinical, 2016
- Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regenerationJournal of Controlled Release, 2015
- mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational RegulationCell Metabolism, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesisThe Journal of Pathology, 2001